CORC

在结果中检索

CORC

浏览/检索结果: 共74条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells 期刊论文
GENOMICS, 2021, 卷号: 113, 期号: 3, 页码: 1057-1069
作者:  Liu, Yuwei;  Xue, Mengzhu;  Cao, Danyan;  Qin, Lihuai;  Wang, Ying
收藏  |  浏览/下载：33/0  |  提交时间：2021/08/17
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+
作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong
收藏  |  浏览/下载：22/0  |  提交时间：2020/12/24
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 卷号: 30, 期号: 9, 页码: 10
作者:  Hou, Zeng;  Min, Wenjian;  Zhang, Rukang;  Niu, Ao;  Li, Yuanqing
收藏  |  浏览/下载：44/0  |  提交时间：2020/07/01
Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 180, 页码: 171-190
作者:  Liu, Ruiqi;  Zhang, Zhuqing;  Yang, Hong;  Zhou, Kaixin;  Geng, Meiyu
收藏  |  浏览/下载：9/0  |  提交时间：2020/07/01
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430
作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载：22/0  |  提交时间：2020/07/01
Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search 期刊论文
MOLECULES, 2018, 卷号: 23, 期号: 3
作者:  Ding, Hong;  Lu, Wen Chao;  Hu, Jun Chi;  Liu, Yu-Chih;  Zhang, Chen Hua
收藏  |  浏览/下载：50/0  |  提交时间：2019/01/08
Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression 期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 3, 页码: 821-831
作者:  Wang, Yu-Ting;  Yuan, Bo;  Chen, Hua-Dong;  Xu, Lin;  Tian, Yu-Nan
收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08
Pharmacologic characterization of SHR8443, a novel dual inhibitor of phosphatidylinositol 3-kinase and mammalian target of rapamycin 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 64, 页码: 107977-107990
作者:  Xie, Chengying;  Chen, Xiangling;  Zheng, Mingyue;  Liu, Xiaohong;  Wang, Hongbin
收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08
New Insights into PI3K Inhibitor Design using X-ray Structures of PI3K alpha Complexed with a Potent Lead Compound 期刊论文
SCIENTIFIC REPORTS, 2017, 卷号: 7
作者:  Yang, Xiuyan;  Zhang, Xi;  Huang, Min;  Song, Kun;  Li, Xuefen
收藏  |  浏览/下载：21/0  |  提交时间：2019/01/08
The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma 期刊论文
CANCER LETTERS, 2017, 卷号: 408, 页码: 102-111
作者:  Zhao, Yang;  Qi, Xinming;  Chen, Jing;  Wei, Wenxin;  Yu, Cunzhi
收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace